The head lice drug ivermectin is being touted as a coronavirus killer. But studies suggest it would need to be taken in mega-doses far higher than those currently used, with unknown side-effects.
Academic rigor, journalistic flair
Articles on ivermectin
Displaying all articles
The head lice drug Ivermectin has stopped SARS-CoV-2, the virus that causes COVID-19, from replicating in lab tests. But we don't know if it will work as a treatment for people with coronavirus.
A cure for many tropical diseases was discovered 30 years ago this month. The drug is donated by its manufacturer. Why are we still dealing with neglected tropical diseases?
Although a drug of known safety and efficacy is available, scabies still affects more than 100 million people across the world.
The 2015 Nobel Prize in medicine went to research on remedies derived from natural compounds. Academia is continuing the fight against 'neglected' diseases by similarly hunting for new drugs in nature.
Top contributors
-
Andrew McLachlan is a Friend of The Conversation.Head of School and Dean of Pharmacy, University of Sydney
-
Associate Professor of Chemistry, Northeastern University
-
Professor of Chemistry, Northeastern University
-
Group Leader, Murdoch Childrens Research Institute. Associate Professor, Department of Paediatrics, University of Melbourne. Paediatric Infectious Diseases Physician, Royal Children's Hospital, Murdoch Children's Research Institute
-
Ph.D. Candidate in Microbiology, Harvard University
